Universal Cancer-Detecting Liquid Biopsy Approaches Market

A new cancer detection test called TumorScanTM may be the first universal liquid biopsy to be introduced into the market. Developed at the University of Bradford, the test, alongside other methods, will use a "rule in, or rule out" strategy to determine if cancer is present in patients. By using ultraviolet light to analyze DNA damage in white blood cells, the test is able to identify measurable differences in how susceptible cells are to further damage in individuals with cancer. Damage within ...

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.